SHARE

Shares of Hologic, Inc. (NASDAQ:HOLX) ended Wednesday session in red amid volatile trading. The shares closed down -1.07 points or -2.84% at $36.60 with 3.40 million shares getting traded. Post opening the session at $37.47, the shares hit an intraday low of $36.44 and an intraday high of $37.58 and the price vacillated in this range throughout the day. The company has a market cap of $10.02 billion and the numbers of outstanding shares have been calculated to be 277.42 million shares.

Hologic, Inc. (HOLX) announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the company’s Aptima® Zika virus diagnostic assay to be used with urine samples (collected alongside patient-matched serum or plasma specimens).

Hologic’s Zika virus assay was authorized for emergency use with serum and plasma (blood) samples in June 2016.  Its new use with urine samples lengthens the time period during which patients can be tested for Zika from seven days to 14 days following symptoms, as recommended by the U.S. Centers for Disease Control and Prevention (CDC).

“This action by FDA is significant because it gives many more people the opportunity to be tested with our highly sensitive assay,” said Tom West, Division President of Diagnostic Solutions at Hologic. “In particular, this expanded indication allows us to better serve public health labs, increasing access to more people to detect and diagnose more disease.”

Shares of Skyline Medical Inc (NASDAQ:SKLN) ended Wednesday session in red amid volatile trading. The shares closed down -0.006 points or -5.32% at $0.105 with 1.00 million shares getting traded. Post opening the session at $0.11, the shares hit an intraday low of $0.10 and an intraday high of $0.11 and the price vacillated in this range throughout the day. The company has a market cap of $8.43 million and the numbers of outstanding shares have been calculated to be 81.80 million shares.

Skyline Medical Inc (SKLN) manufactures environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care in the United States. It offers the STREAMWAY Fluid Management System that suctions surgical waste fluid from the patient using standard surgical tubing. The company’s system replaces the manual process of collecting fluids in canisters, and transporting and dumping in sinks outside of the operating room.

 

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here